Zosano Pharma Corp Deferred Offering Costs
Zosano Pharma Corp had Deferred Offering Costs of $67.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2022-05-13
- 2022-03-31: Deferred Offering Costs $67.00K.
- 2021-12-31: Deferred Offering Costs $85.00K.
- 2021-09-30: Deferred Offering Costs $75.00K.
- 2021-06-30: Deferred Offering Costs $210.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2022-03-31 | $67.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $85.00K 10-Q · filed 2022-05-13 |
| 2021-09-30 | $75.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $210.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $70.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $48.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $48.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $77.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $107.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $65.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2019-03-31 | $517.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $114.00K 10-K · filed 2020-03-13 |
| 2018-03-31 | $618.90K 10-Q · filed 2018-05-15 |